Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty
Keyword(s):
Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an incidence of 0.2% to 0.5%. We report the case of a 50-year-old man who developed thrombocytopenia after tirofiban use (both intracoronary and peripheral) over hours and the successful management of this complication after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
2019 ◽
Vol 73
(15)
◽
pp. S14-S15
2014 ◽
Vol 35
(36)
◽
pp. 2460-2467
◽
2016 ◽
Vol 67
(23)
◽
pp. 2705-2715
◽
2015 ◽
Vol 6
(7)
◽
pp. 650-658
◽